BrightSpec’s spectraMRR™ Wins Prestigious 2025 R&D 100 Award
Waltham, MA– Sept 3, 2025 – BrightSpec, a leader in next-generation spectroscopy solutions, today announced that its spectraMRR™ platform has been selected as a winner of the 2025 R&D 100 Awards in the Analytical/Test category.
The R&D 100 Awards have honored the world’s most pioneering technologies since 1963, celebrating breakthroughs across disciplines ranging from biotechnology and energy to advanced materials and analytical tools. Winners are chosen by an independent panel of international industry experts based on novelty, impact, and potential to transform science and industry.
“Winning an R&D 100 Award recognizes a new way forward in analytical science,” said Walter Colsman, CEO of BrightSpec. “By integrating computational chemistry with laboratory analytics, Molecular Rotational Resonance (MRR) gives researchers more precise answers, faster, through a digital approach that scales from method development to routine analysis—advancing discovery across pharma, the chemical industry, and beyond.”
About the spectraMRR™
The spectraMRR™ is the first commercial platform powered by Molecular Rotational Resonance (MRR) spectroscopy. MRR provides unparalleled structural insight by directly analyzing rotational spectra at room temperature, enabling scientists to:
- Differentiate and quantify isomers in complex mixtures
- Eliminate the need for separation, reference standards, or extensive sample preparation
- Deliver high-resolution, reproducible results in real time
With its combination of speed, precision, and ease of use—and its integration of computational models with automated data analysis—spectraMRR opens new possibilities for applications in pharmaceuticals, the chemical industry, and consumer goods, where accurate structural characterization and impurity detection are critical.
Global Recognition
The 2025 R&D 100 Awards competition drew submissions from 13 countries and regions, reflecting the global scale of innovation in science and technology. BrightSpec is honored to be recognized alongside world-class institutions such as NASA, Sandia National Laboratories, Oak Ridge National Laboratory, MIT Lincoln Laboratory, and Thermo Fisher Scientific.
About BrightSpec
BrightSpec is advancing the frontier of molecular spectroscopy with its proprietary Molecular Rotational Resonance (MRR) technology. By combining quantum simulation, computational chemistry, advanced spectrometer design, data analysis, and automation, BrightSpec delivers solutions that address complex challenges in pharmaceuticals, the chemical industry, life sciences, and consumer goods.
Learn more at www.brightspec.com.
Media Contact:
Kate Marcus
Sr. Marketing Manager, BrightSpec
kate.marcus@brightspec.com